Early prehabilitation in suspected locally advanced and metastatic lung cancer
Lung cancer is the most common cause of cancer death in the UK. Our study aims to assess whether early prehabilitation is feasible in these patients. Many patients aren’t fit for anticancer treatment, due to a combination of burden of disease, patient fitness and comorbidities. These issues affect energy levels and performance status, which results […]